Literature DB >> 6284807

The effect of post-infection immunization on the severity of experimental visna.

N Nathanson, J R Martin, G Georgsson, P A Palsson, R E Lutley, G Petursson.   

Abstract

Mesh：

Substances：

Year:  1981        PMID： 6284807     DOI： 10.1016/0021-9975(81)90023-2

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN： 0021-9975            Impact factor:   1.311


× No keyword cloud information.
  8 in total

1.  Immune response to individual maedi-visna virus gag antigens.

Authors:  Inderpal Singh; Ian McConnell; Barbara Blacklaws
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

2.  Expression of viral antigens in the central nervous system of visna-infected sheep: an immunohistochemical study on experimental visna induced by virus strains of increased neurovirulence.

Authors:  G Georgsson; D J Houwers; P A Pálsson; G Pétursson
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

Review 3.  Animal virus infections that defy vaccination: equine infectious anemia, caprine arthritis-encephalitis, maedi-visna, and feline infectious peritonitis.

Authors:  N C Pedersen
Journal:  Adv Vet Sci Comp Med       Date:  1989

4.  Early events in immune evasion by the lentivirus maedi-visna occurring within infected lymphoid tissue.

Authors:  P Bird; B Blacklaws; H T Reyburn; D Allen; J Hopkins; D Sargan; I McConnell
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

5.  Persistence of visna virus in cultured ferret brain cortex and fibroblasts.

Authors:  R S Trowbridge; J F Schneider; R Haddad
Journal:  In Vitro       Date:  1983-04

6.  Primary demyelination in visna. An ultrastructural study of Icelandic sheep with clinical signs following experimental infection.

Authors:  G Georgsson; J R Martin; J Klein; P A Pálsson; N Nathanson; G Pétursson
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

Review 7.  Important mammalian veterinary viral immunodiseases and their control.

Authors:  J R Patel; J G M Heldens; T Bakonyi; M Rusvai
Journal:  Vaccine       Date:  2012-01-17       Impact factor: 3.641

8.  A rat model of human T lymphocyte virus type I (HTLV-I) infection. 1. Humoral antibody response, provirus integration, and HTLV-I-associated myelopathy/tropical spastic paraparesis-like myelopathy in seronegative HTLV-I carrier rats.

Authors:  N Ishiguro; M Abe; K Seto; H Sakurai; H Ikeda; A Wakisaka; T Togashi; M Tateno; T Yoshiki
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.